FRET measurements between small numbers of molecules identifies subtle changes in receptor interactions

Overexpression of HER2 alters the cellular behavior of EGF receptor (EGFR) and itself, with great implications on cell fate. To understand the molecular interactions underlying these alterations, we quantified the association between the two receptors by looking at efficiency changes in fluorescence resonance energy transfer (FRET) between a small number of molecules at the membrane of living cells. Human mammary epithelial (HME) cells expressing varying degrees of HER2 were studied, to identify and compare the degree of receptors interactions as a function of HER2 overexpression. A high resolution wide-field laser microscope combined with a high sensitivity cooled CCD camera was used to capture simultaneously donor and acceptor emissions. Alternating between green and red lasers every 80 msec, donor, FRET, and acceptor images were acquired and were used to calculate FRET efficiency. Automated image analysis was developed to create FRET efficiency maps from overlapping donor, acceptor and FRET images, and derive FRET efficiency histograms to quantify receptor-receptor interactions pixel by pixel. This approach enabled us to detect subtle changes in the average distance between EGFR molecules, and between EGFR and HER2. We found pre-existing EGFR homoassociations, and EGFR-HER2 heteroassociations in cells overexpressing HER2, and identified the changes in these interactions with ligand stimulation. These observations demonstrate the power of FRET measurements between small numbers of molecules in identifying subtle changes in molecular interactions in living cell.

[1]  Sándor Damjanovich,et al.  Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2 , 2002, Journal of Cell Science.

[2]  Michael Kofler,et al.  The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. , 2003, Molecular cell.

[3]  Edouard C. Nice,et al.  Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor α , 2002, Cell.

[4]  S. Weiss Fluorescence spectroscopy of single biomolecules. , 1999, Science.

[5]  H. Blau,et al.  Monitoring protein-protein interactions in intact eukaryotic cells by beta-galactosidase complementation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Gaudenz Danuser,et al.  FRET or no FRET: a quantitative comparison. , 2003, Biophysical journal.

[8]  Michelle Palmer,et al.  Epidermal growth factor receptor dimerization monitored in live cells , 2000, Nature Biotechnology.

[9]  H. Steven Wiley,et al.  Quantitative Analysis of HER 2-mediated Effects on HER 2 and Epidermal Growth Factor Receptor Endocytosis DISTRIBUTION OF HOMO-AND HETERODIMERS DEPENDS ON RELATIVE HER 2 LEVELS * , 2003 .

[10]  T M Jovin,et al.  Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation , 1995, The Journal of cell biology.

[11]  Douglas Lauffenburger,et al.  Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects. , 2003, Cancer research.

[12]  A. M. Stanley,et al.  Structure of the extracellular region of HER 2 alone and in complex with the Herceptin Fab , 2022 .

[13]  Manfred Dietel,et al.  Involvement of the c‐erbB‐2 oncogene product in the egf‐induced cell motility of sk‐ov‐3 ovarian cancer cells , 1999 .

[14]  Thomas Schmidt,et al.  Simultaneous dual-color and dual-polarization imaging of single molecules , 2000 .

[15]  S. Michnick,et al.  Oligomerization domain-directed reassembly of active dihydrofolate reductase from rationally designed fragments. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Jae-Hoon Kim,et al.  Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains , 2002, Cell.

[17]  Hyun-soo Cho,et al.  EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. , 2003, Molecular cell.

[18]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[19]  Andrew B. Martin,et al.  Single-molecule protein folding: diffusion fluorescence resonance energy transfer studies of the denaturation of chymotrypsin inhibitor 2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M Dahan,et al.  Single-pair fluorescence resonance energy transfer on freely diffusing molecules: observation of Förster distance dependence and subpopulations. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Assmann,et al.  c‐erbB‐2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  Jie Leng,et al.  ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases , 2000, The Journal of cell biology.

[23]  I. Wilson,et al.  Erythropoietin receptor activation by a ligand-induced conformation change. , 1999, Science.

[24]  C R King,et al.  erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. , 1987, Science.

[25]  D. Lauffenburger,et al.  Quantitative Analysis of HER2-mediated Effects on HER2 and Epidermal Growth Factor Receptor Endocytosis , 2003, Journal of Biological Chemistry.

[26]  S J Lockett,et al.  EGF-induced redistribution of erbB2 on breast tumor cells: flow and image cytometric energy transfer measurements. , 1998, Cytometry.

[27]  G. Schütz,et al.  Direct observation of ligand colocalization on individual receptor molecules. , 1998, Biophysical journal.

[28]  Jie Leng,et al.  ErbB 2 Is Necessary for Induction of Carcinoma Cell Invasion by ErbB Family Receptor Tyrosine Kinases , 2000 .